Politico August 10, 2020
By Zachary Brennan

Several candidates are in late-stage clinical trials.

It took just 63 days from the time the company started designing its vaccine to launch the first clinical trial, a rapid pace made possible in part by Moderna’s use of genetic material called messenger RNA. When that mRNA is injected into a patient, it directs cells to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
ONC @ 20: A Tale of Optimism and Humility
Europe Strengthens Future Disease Defense
HIV Transmission Linked To Vampire Facials, Says CDC
Identifying Vulnerable Populations to Substandard or Falsified Drugs: A Global Health Challenge
Community Notes effectively targets medical misinformation on X

Share This Article